Tuesday, May 19, 2020 1:19:48 PM
Very Interesting Response From Japanese Nobel Prize Winner
Japan's Nobel prize winning Professor of Medicine, Professor Dr Tasuku Honjo, created a sensation today by saying that the Coronavirus is not natural.
"If it is natural, it wouldn't have adversely affected the entire world like this. Because, as per nature, temperature is different in different countries. If it is natural, it would adversely affect only those countries having the same temperature as China. Instead, it is spreading in a country like Switzerland, in the same way it is spreading in the desert areas. Whereas if it were natural, it would have spread in cold places, but died in hot places.
I have done 40 years of research on animals and viruses. It is not natural. It is manufactured and the virus is completely artificial. I have worked for 4 years in the Wuhan laboratory in China. I am fully acquainted with all the staff of that laboratory. I have been phoning them all, after the Coronavirus surfaced. But all their phones are dead for the last 3 months. It is now understood that all these lab technicians have died.
Based on all my knowledge and research till date, I can say this with 100% confidence - That the Coronavirus is not natural. It did not come from bats. China manufactured it. If what I am saying today is proved false now or even after my death, the government can withdraw my Nobel Prize. China is lying and this truth will one day be revealed to everyone".
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM